CX 2024 Preliminary Programme
Day 2: Venous & Lymphatic Controversies - Wednesday, 24th April
Venue: Theatre 2
Appropriate Care Controversies
Anatomical disease classification to optimise decision making and outcomes for deep venous recanalisation procedures
| Speaker: | Houman Jalaie, Aachen, Germany |
Audience participation & discussion
Summary of latent guidelines regarding optimal use of IVC filters
| Speaker: | Tze Chan, Liverpool, United Kingdom |
Audience participation & discussion
Optimum outcomes and duration of follow-up for superficial venous ablation clinical trials
| Speaker: | Lowell Kabnick, New Jersey, United States |
Audience participation & discussion
Optimum outcomes and duration of follow-up in acute and chronic deep venous trials
| Speaker: | Steven Abramowitz, Washington, United States |
Audience participation & discussion
Venous outcomes that should be measured in routine clinical practice
| Speaker: | Daniel Carradice, Kingston Upon Hull, United Kingdom |
Audience participation & discussion
Underutilisation of thrombus removal intervention for pulmonary emboli
Audience participation & discussion
Lytic-free options for early thrombus removal in acute pulmonary embolus
Audience participation & discussion
Potential interventions for chronic femoropopliteal deep venous obstruction
Audience participation & discussion
Current status of DOACs in the prevention and treatment of venous thromboembolic disease
| Speaker: | Armando Mansilha, Porto, Portugal |
Audience participation & discussion
The justification for, and success of, treatments for prominent hand and face veins
| Speaker: | Aleksandra Jaworucka-Kaczorowska, Gorzow Wielkopolski, Poland |
Audience participation & discussion
Sponsored education
Deep Venous Controversies
Debate: Treatment of non-thrombotic iliac vein lesions in C3-C6 disease is supported by the clinical evidence
For the motion
| Steve Elias, Englewood, United States |
Against the motion
| Gerard O’Sullivan, Galway, Ireland |
Audience participation & discussion
Edited Case: Complex deep venous recanalisation with inflow disease
| Speaker: | Marie Josee Van Rijn, Nijmegen, Netherlands |
Audience participation & discussion
Podium First: Defining the need for a dedicated IVC stent
| Speaker: | Stephen Black, London, United Kingdom |
Audience participation & discussion
Optimal algorithm for managing combined iliac outflow obstruction and pelvic venous disease
| Speaker: | Gloria Salazar, Chape Hill, United States |
Audience participation & discussion
Mechanical thrombectomy for early thrombus removal in DVT: Current landscape
| Speaker: | Kush Desai, Chicago, United States |
Audience participation & discussion
When and how to manage patients presenting with acute DVT and underlying culprit lesion
| Speaker: | TBA |
Audience participation & discussion
Podium First: Efficacy results of the SAVVE trial: Long term results use of a bioprosthetic valve, for patients with chronic deep venous refllux
| Speaker: | Marc Glickman, Irvine, United States |
Audience participation & discussion
Summary of currently available venous stent trial data
| Speaker: | Erin Murphy, Charlotte, United States |
Audience participation & discussion
Ideal strategy for maintaining venous stent patency: Role of surveillance, thresholds for re-intervention and anticoagulation tactics
Audience participation & discussion
VIVID study: 12 month outcomes
| Speaker: | Michael Lichtenberg, Arnsberg, Germany |
Audience participation & discussion
Sponsored education
Superficial Venous Controversies
Debate: Compression should be routine after endovenous interventions
For the motion
| Alun Davies, London, United Kingdom |
Against the motion
| Nicolas Neaume, Toulouse, France |
Audience participation & discussion
The role of phlebectomy alone without saphenous ablation for varicose veins: insights from the SAPTAP trial
| Speaker: | Eveline Scheerders, Rotterdam, Netherlands |
Audience participation & discussion
Edited case: Multi-session sclerotherapy in a patient with extensive C1 disease
| Speaker: | Enric Roche, Barcelona, Spain |
Audience participation & discussion
Podium First: Randomised clinical trials comparing cyanoacrylate glue closure with thermal ablation and surgical stripping: Study design and methodology
| Faculty: | Manj Gohel, Cambridge, United Kingdom |
| Kathleen Gibson, Bellevue, United States |
Audience participation & discussion
Ideal indications and optimum techniques for treatment of incompetent perforators
Audience participation & discussion
Sponsored education
Venous Ulcer and Lymphatic Controversies
Edited case: Venous ulcer management in a patient with extensive venous outflow obstruction
Audience participation & discussion
Highlighting the easy victories when managing patients with swollen legs and lymphoedema
| Speaker: | Kristiana Gordon, London, United Kingdom |
Audience participation & discussion
Non-venous diagnoses that mimic skin changes in C4 - C6 venous disease
| Speaker: | Raghu Kolluri, Columbus, United States |
Audience participation & discussion
Edited Case: Technical considerations for optimal embolisation of low-flow vascular malformations
| Speaker: | Jocelyn Brooks, London, United Kingdom |
Audience participation & discussion
Pelvic Venous Controversies
Edited Case: Optimal technique for sclerotherapy of vulval varicosities
| Speaker: | Aleksandra Jaworucka-Kaczorowska, Gorzow Wielkopolski, Poland |
Audience participation & discussion
Treatment of pelvic venous disease to prevent leg varicosity recurrence
Audience participation & discussion
Rationale for an RCT evaluating pelvic vein embolisation: Insights from the EMBOLIZE study
| Speaker: | Ronald Winokur, New York, United States |
Audience participation & discussion
The unbreakable rules of pelvic venous management
| Speaker: | Sriram Narayanan, Singapore, Singapore |
Audience participation & discussion